Table 5 |
|||||||||||
|
Weighted residual error (WRE), weighted residual sum of squares (WRSS) and Akaike number for each solute, adipose model and time period |
|||||||||||
|
Solute |
Time period |
Data (# pts) |
N = 1 |
N = 2 |
N = 3 |
||||||
|
WRE |
WRSS |
Akaike |
WRE |
WRSS |
Akaike |
WRE |
WRSS |
Akaike |
|||
|
|
|||||||||||
|
Isoflurane_S |
1 |
45 |
0.062 |
0.329 |
-50.0264 |
0.0572 |
0.285 |
-54.487 |
0.0575 |
0.284 |
-52.6451 |
|
2 |
5 |
0.41 |
1.004 |
0.01996 |
0.0224 |
0.329 |
-3.55849 |
0.169 |
0.182 |
-4.51874 |
|
|
3 |
10 |
0.44 |
3.94 |
13.71181 |
0.12 |
0.24 |
-12.2712 |
0.125 |
0.226 |
-10.8722 |
|
|
Isoflurane_D |
1 |
45 |
0.047 |
0.186 |
-75.6904 |
0.0385 |
0.116 |
-94.9374 |
0.0375 |
0.11 |
-95.3274 |
|
2 |
6 |
0.37 |
1.044 |
0.258357 |
0.189 |
0.285 |
-5.5316 |
0.131 |
0.14 |
-7.79668 |
|
|
3 |
9 |
0.32 |
1.096 |
0.825005 |
0.127 |
0.248 |
-10.5489 |
0.119 |
0.16 |
-12.4932 |
|
|
Sevoflurane |
1 |
45 |
0.0729 |
0.386 |
-42.8363 |
0.0664 |
0.332 |
-47.6179 |
0.0648 |
0.32 |
-47.2745 |
|
2 |
5 |
0.39 |
0.955 |
-0.23022 |
0.242 |
0.364 |
-3.05301 |
0.192 |
0.225 |
-3.45827 |
|
|
3 |
10 |
0.36 |
1.657 |
5.050087 |
0.215 |
0.573 |
-3.5687 |
0.103 |
0.171 |
-13.6609 |
|
|
Desflurane |
1 |
45 |
0.0869 |
0.866 |
-6.47417 |
0.0586 |
0.32 |
-49.2745 |
0.0477 |
0.195 |
-69.564 |
|
2 |
6 |
0.323 |
0.768 |
-1.58379 |
0.167 |
0.204 |
-7.53781 |
0.119 |
0.114 |
-9.02934 |
|
|
3 |
9 |
5.08 |
1416 |
65.30032 |
0.196 |
0.641 |
-2.00253 |
0.139 |
0.338 |
-5.76238 |
|
|
|
|||||||||||
|
Levitt BMC Clinical Pharmacology 2007 7:1 doi:10.1186/1472-6904-7-1 |
|||||||||||
